Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Lexicon Pharmaceuticals Inc’s stock clocked out at $0.70, up 1.73% from its previous closing price of $0.69. In other words, the price has increased by $1.73 from its previous closing price. On the day, 3.21 million shares were traded.
Ratios:
To gain a deeper understanding of LXRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.44 and its Current Ratio is at 5.44. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on March 05, 2025, Downgraded its rating to Market Perform and sets its target price to $1 from $2 previously.
On June 17, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On April 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $5.Leerink Partners initiated its Outperform rating on April 30, 2024, with a $5 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when COATS LONNEL bought 300,000 shares for $1.60 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.19 while its Price-to-Book (P/B) ratio in mrq is 1.74.
Stock Price History:
Over the past 52 weeks, LXRX has reached a high of $2.45, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 39.60%, while the 200-Day Moving Average is calculated to be -35.23%.
Shares Statistics:
A total of 361.49M shares are outstanding, with a floating share count of 180.38M. Insiders hold about 50.33% of the company’s shares, while institutions hold 34.49% stake in the company.
